Rhabdomyolysis induced by fenofibrate monotherapy;Rhabdomyolyse induite par le fénofibrate en monothérapie

Revue de Medecine Interne

Volumn 27, Issue 7, 2006, Pages 573-574

  Archambeaud Mouveroux, F ^a   Lopez, S ^a   Combes, C ^a   Lassandre, S ^a   Amaniou, M ^b   Teissier, M P ^a   Galinat, S ^a  

^a Hopital du Cluzeau   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Fenofibrate; Fibrate; Rhabdomyolysis

Indexed keywords

FENOFIBRATE; GLICLAZIDE; STATIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; HUMAN; HYPOTHYROIDISM; KIDNEY FAILURE; MONOTHERAPY; RHABDOMYOLYSIS; TIME; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; DYSLIPIDEMIA; FOLLOW UP; MALE; MIDDLE AGED;

ANTILIPEMIC AGENTS; DIABETES MELLITUS; DRUG INTERACTIONS; DYSLIPIDEMIAS; FOLLOW-UP STUDIES; GLICLAZIDE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROCETOFEN; RHABDOMYOLYSIS;

EID: 33745684990     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.02.013     Document Type: Article

References (9)

1. Black C, Jick H. Etiology and frequency of rhabdomyolysis-Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, Massachusetts.
2. Lavarenne J., and Poinas-Caillaud H. Atteintes musculaires et fibrates. Thérapie 46 (1991) 347-349
3. Graham D.J., Staffa J.A., Shatin D., Andrade S.E., Schech S.D., La Grenade L., et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292 (2004) 2585-2590
4. Ehrhardt M., Lindenmaier H., Burhenne J., Haefeli W.E., and Weiss J. Influence of lipid lowering fibrates on P-glycoprotein activity in vitro. Biochemic Pharmacol. 67 (2004) 285-292
5. Schlienger J.L., Goichot B., Grunenberger F., and Pradignac A. Révélation d'une myopathie thyroïdienne par un fibrate. Rev. Med. Interne 17 (1996) 169-170
6. Barker B., Goodenough R., and Falko J. Fenofibrate monotherapy induced rhabdomyolysis. Diabetes Care 26 (2003) 2482-2483
7. Layne R.D., Sehbai A.S., and Stark J.L. Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy. Ann. Pharmacother. 38 (2004) 232-234
8. Dourakis S.P., Tzemanakis E., Sinani C., Kafiri G., and Hadziyannis S.J. Gliclazide-induced acute hepatitis. Eur. J. Gastroenterol. Hepatol. 12 (2000) 119-121
9. Yang K.C., Fang C.C., Su T.C., and Lee Y.T. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD. Am. J. Kidney Dis. 45 (2005) 57-60